New migraine treatments cut attacks by half in some patients
CGRP inhibitors and Botox injections reduce migraine episodes by 50 per cent for some patients. This works when traditional preventers fail.
Karen Fisher, 59, spent more than a decade battling vestibular migraines that left her bedridden and contributed to her decision to retire from nursing early. Nausea and light sensitivity made a plane journey so severe she was taken off at Singapore Airport.
Diagnosed with migraines in 2025. CGRP inhibitors and Botox can reduce episodes by 50 per cent in some cases.
About 3.9 million Australians suffer migraines, females more than twice as likely as males.
- 3.9 million
- Australians with migraines
- more than twice as likely
- Female to male ratio
- 50 per cent for some patients
- Episode reduction
- 2025
- Fisher's diagnosis year
Why it mattersAbout 3.9 million Australians endure disabling migraines with no relief from standard drugs. These new options offer hope where older treatments have failed.
AustraliaNew treatment pathways are available through Australian prescription for migraine sufferers when conventional preventers don't work, though access varies by specialist availability and cost.
✓ Claims checked against the source and corrected before publish. checked 4 d ago
